Patient engagement and more cutting topics across the biopharmaceutical industry|Adam Goulburn,Co-founder,Dimension 00:10:00
Adam invests at the intersection of biology, healthcare, technology and data. He is interested in the digitization of healthcare; genomics and coding biology; the microbiome; bionics and cyborgs; neuroscience and brain-computer interfaces; next-gen bio-imaging; regenerative medicine; synthetic biology; human performance; and other areas of appliedhard sciences
